Browse > Article
http://dx.doi.org/10.4070/kcj.2014.44.2.122

A Case of Sudden Cardiac Death due to Pilsicainide-Induced Torsades de Pointes  

Nakatani, Shimpei (Division of Cardiology, Osaka Rosai Hospital)
Taniike, Masayuki (Division of Cardiology, Osaka Rosai Hospital)
Makino, Nobuhiko (Division of Cardiology, Osaka Rosai Hospital)
Egami, Yasuyuki (Division of Cardiology, Osaka Rosai Hospital)
Shutta, Ryu (Division of Cardiology, Osaka Rosai Hospital)
Tanouchi, Jun (Division of Cardiology, Osaka Rosai Hospital)
Nishino, Masami (Division of Cardiology, Osaka Rosai Hospital)
Publication Information
Korean Circulation Journal / v.44, no.2, 2014 , pp. 122-124 More about this Journal
Abstract
An 84-year-old male received oral pilsicainide, a pure sodium channel blocker with slow recovery kinetics, to convert his paroxysmal atrial fibrillation to a sinus rhythm; the patient developed sudden cardiac death two days later. The Holter electrocardiogram, which was worn by chance, revealed torsade de pointes with gradually prolonged QT intervals. This drug is rapidly absorbed from the gastrointestinal tract, and most of it is excreted from the kidney. Although the patient's renal function was not highly impaired and the dose of pilsicainide was low, the plasma concentration of pilsicainide may have been high, which can produce torsades de pointes in the octogenarian. Although the oral administration of class IC drugs, including pilsicainide, is effective to terminate atrial fibrillation, careful consideration must be taken before giving these drugs to octogenarians.
Keywords
Pilsicainide; Torsades de pointes; Sudden cardiac death;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Alboni P, Botto GL, Baldi N, et al. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. N Engl J Med 2004;351:2384-91.   DOI
2 Atarashi H, Inoue H, Hiejima K, Hayakawa H. Conversion of recent-onset Atrial Fibrillation by a single oral dose of Pilsicainide (Pilsicainide Suppression Trial on atrial fibrillation). The PSTAF Investigators. Am J Cardiol 1996;78:694-7.   DOI
3 Kaneko Y, Nakajima T, Kato T, Kurabayashi M. Pilsicainide-induced polymorphic ventricular tachycardia. Intern Med 2012;51:443-4.   DOI
4 Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 1989;321:406-12.   DOI   ScienceOn